𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐓𝐫𝐚𝐜𝐤 𝐚𝐧𝐝 𝐓𝐫𝐚𝐜𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬 𝐀𝐍𝐃 𝐅𝐮𝐧𝐝𝐢𝐧𝐠

𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐓𝐫𝐚𝐜𝐤 𝐚𝐧𝐝 𝐓𝐫𝐚𝐜𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬 𝐀𝐍𝐃 𝐅𝐮𝐧𝐝𝐢𝐧𝐠

Implementing and operating a national pharmaceutical Track and Trace platform can be expensive. Beyond the initial investment, these systems require ongoing funding to support infrastructure, maintenance, operations, and continuous development.

Different countries follow different approaches to funding their national platforms.

𝑪𝒐𝒎𝒎𝒐𝒏 𝒎𝒐𝒅𝒆𝒍𝒔 𝒊𝒏𝒄𝒍𝒖𝒅𝒆:

𝟏. 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭-𝐅𝐮𝐧𝐝𝐞𝐝 𝐌𝐨𝐝𝐞𝐥

The government covers the costs of developing, operating, and maintaining the national platform through public budgets or dedicated government allocations.

𝟐. 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥

Manufacturers and importers purchase packages based on the number of serial numbers they need to use. Once the allocated quantity is consumed, they purchase another package.

𝟑. 𝐓𝐫𝐚𝐧𝐬𝐚𝐜𝐭𝐢𝐨𝐧 𝐕𝐚𝐥𝐮𝐞-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥

Funding is linked to the value of pharmaceutical invoices, with different rates potentially applied to imported and locally manufactured medicines.

𝟒. 𝐏𝐚𝐲-𝐏𝐞𝐫-𝐂𝐨𝐝𝐞 𝐌𝐨𝐝𝐞𝐥

Manufacturers and importers pay a fee for each Crypto Code or Marking Code issued by the national system.

𝟓. 𝐍𝐨𝐧-𝐏𝐫𝐨𝐟𝐢𝐭 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐅𝐮𝐧𝐝𝐢𝐧𝐠

Non-profit organizations, development agencies, or international partners may support the establishment or improvement of national traceability platforms through grants, technical assistance, or capacity-building programs.

𝟔. 𝐏𝐮𝐛𝐥𝐢𝐜-𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 (𝐏𝐏𝐏)

A private-sector operator develops or operates the platform under an agreement with the government, with responsibilities, costs, and revenue arrangements defined by the contract.

𝟕. 𝐇𝐲𝐛𝐫𝐢𝐝 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐌𝐨𝐝𝐞𝐥

The national platform combines multiple funding sources, such as government allocations, industry fees, code issuance charges, or external grants.

These models illustrate how countries can approach the funding of their national pharmaceutical Track and Trace platforms, depending on their regulatory frameworks and implementation strategies.